And the EMA goes to ... Amsterdam

Recommendation
27/28 May 2025
Supervision of the Pharmaceutical Quality System: Challenges and Opportunities
It almost came to a penalty shoot out. But maybe there was no equipment available. So the final decision was made by drawing the name of the new EMA location out of a hat. How could that happen?
Four cities were in a final round: Bratislava, Copenhagen, Milan and Amsterdam. In the next voting rounds, Bratislava and Copenhagen were kicked out. The final draw led to a tie between Amsterdam and Milan (13 votes each - out of 26 Member States). So the decision of the new location was made by drawing lots. As a result, Amsterdam will be the new host of the agency, after Britain leaves the EU.
The decision now taken by the Member followed an assessment by the European Commission and EMA of formal applications, submitted by 19 Member States.
According to a EMA statement, the Agency "will begin working immediately with the Dutch government to prepare for the move and take up its operations in Amsterdam on 30 March 2019 at the latest". EMA will also publish a monitoring chart on its website that will allow stakeholders to track progress.
Related GMP News
07.05.2025FDA is extending its Quality Management Maturity Programme
30.04.2025FDA Warning Letter on missing Audit Trails and Raw Data Review
23.04.2025New WHO Guideline Package: TRS 1060 published
16.04.2025EMA: QPs must provide a written final Assessment and Approval of Third-Party Audit Reports
15.04.2025Strategic Report published by the Critical Medicines Alliance
09.04.2025EMA's Plans for the next three Years